Acerca deEmpresas
AyudaPrivacidadTérminos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos

BIOSCRIPT MIDCO 2 LIMITED

🇬🇧Reino Unido•Private Limited Company (Ltd.)•Activa

Resumen

País🇬🇧Reino Unido
EstadoActiva
Número de registro13212966
Fundada19/2/2021
Objeto socialActivities of other holding companies n.e.c.
DirecciónSuite A, Greenway House Larkwood Way, Tytherington Business Park, Macclesfield, SK10 2XR
Declaración de confirmaciónPróximo vencimiento: 6/2/2027; Última elaboración: —

Legal y estado

Forma legalPrivate Limited Company (Ltd.)
EstadoActiva
Fecha de registro19/2/2021
Autoridad registralCompanies House
Capital registrado—

Fuente: UK Companies House · Última actualización: 3/12/2025

Línea temporal (24 eventos)

2/4/2026

Dirección actualizada

Suite A, Greenway House Larkwood Way, Tytherington Business Park

27/6/2025

Cuentas anuales presentadas

Full accounts made up to 30 September 2024

Ver archivo en Documentos

19/2/2021

Nombramiento Trevor Stokes (persona)

Nombrado como Director

Red

Este diagrama tiene muchas conexiones. para una mejor experiencia.
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profundidad de la red

Propiedad y gestión

Persons with significant control

Bioscript Midco 1 Limited

75–100% shares · 75–100% voting rights · Right to appoint directors

Nombrado el: 19/2/2021

87.5%
Bioscript Midco 1 Limited

75–100% shares · 75–100% voting rights · Right to appoint directors

Nombrado el: 19/2/2021

87.5%

Officers & directors

James Maxwell

Director

Nombrado el: 15/2/2024

—
Gabrielle Alison Silver

Director

Nombrado el: 2/5/2023

—
Daniel Chaffer

Director

Nombrado el: 7/7/2021 · Dimitió el: 14/7/2023

—

Mostrando 1–5 de 8

1 / 2

Línea temporal de propiedad (2 cambios)

19/2/2021

Nombramiento Bioscript Midco 1 Limited (persona)

Persona con control significativo

19/2/2021

Nombramiento Bioscript Midco 1 Limited (empresa)

owns or controls

Accionistas

NombreParticipaciónVotoDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario final

NombreParticipaciónPaísDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografía

Sede

Suite A

Greenway House Larkwood Way, Tytherington Business Park

Macclesfield

SK10 2XR

Finanzas

Cifras clave de cuentas anuales.

Convertir a

2021

Beneficio / (pérdida): £0

Cifras clave

Beneficio / (pérdida)

2021£0
2022£0
2023£0
2024£0

Otros ingresos

2021£1.628.440
2022£1.628.440
2023£3.652.957
2024£3.913.386

Activo total

2021£2.819.297
2022£2.819.297
2023£7.151.967
2024£7.167.326

Net Assets Liabilities

2021£2.819.297
2022£2.819.297
2023£7.151.967
2024£7.167.326

Equity

2021£2.819.297
2022£2.819.297
2023£7.151.967
2024£7.167.326

Current Assets

2021£29.659.379
2022£29.659.379
2023£37.203.541
2024£44.146.534

Net Current Assets Liabilities

2021£-4761
2022£-4761
2023£-4761
2024£-4761

Total Assets Less Current Liabilities

2021£2.819.297
2022£2.819.297
2023£7.151.967
2024£7.167.326

Debtors

2021£29.659.379
2022£29.659.379
2023£37.203.541
2024£44.146.534

Creditors

2021£29.664.140
2022£29.664.140
2023£37.208.302
2024£44.151.295

Amounts Owed To Group Undertakings

2021£29.659.379
2022£29.659.379
2023£37.208.302
2024£44.151.295

Investments Fixed Assets

2021£2.824.058
2022£2.824.058
2023£7.156.728
2024£7.172.087

Issue Equity Instruments

2021—
2022£2.824.058
2023£4.332.670
2024£900.000

Number Shares Issued Fully Paid

202196.301
202296.301
2023432.342.829
2024432.342.829

Par Value Share

2021£0
2022£0
2023£0
2024£0

Gastos administrativos

2021£4761
2022£4761
2023—
2024—

Accrued Liabilities Deferred Income

2021£4761
2022£4761
2023—
2024—

Amounts Owed By Group Undertakings

2021£29.659.379
2022£29.659.379
2023£37.203.541
2024£44.146.534

Applicable Tax Rate

2021£0
2022£0
2023—
2024—

Audit Fees Expenses

2021£2000
2022£2000
2023—
2024—

Comprehensive Income Expense

2021—
2022£-4761
2023£0
2024£0

Fixed Assets

2021£2.824.058
2022£2.824.058
2023£7.156.728
2024£7.172.087

Further Item Increase Decrease In Equity Component Total Income Expense Recognised Directly In Equity

2021—
2022—
2023—
2024£15.359

Income Expense Recognised Directly In Equity

2021—
2022£2.824.058
2023£4.332.670
2024£15.359

Interest Income From Group Undertakings

2021£1.628.440
2022£1.628.440
2023£3.652.957
2024£3.913.386

Interest Paid To Group Undertakings

2021£1.628.440
2022£1.628.440
2023£3.652.957
2024£3.913.386

Interest Payable Similar Charges Finance Costs

2021£1.628.440
2022£1.628.440
2023£3.652.957
2024£3.913.386

Operating Profit Loss

2021£-4761
2022£-4761
2023—
2024—

Other Interest Receivable Similar Income Finance Income

2021£1.628.440
2022£1.628.440
2023£3.652.957
2024£3.913.386

Percentage Class Share Held In Subsidiary

2021£1
2022£1
2023£1
2024£1

Profit Loss On Ordinary Activities After Tax

2021£-4761
2022£-4761
2023£0
2024£0

Profit Loss On Ordinary Activities Before Tax

2021£-4761
2022£-4761
2023£0
2024£0

Tax Expense Credit Applicable Tax Rate

2021£-905
2022£-905
2023—
2024—

Tax Increase Decrease Arising From Group Relief Tax Reconciliation

2021£905
2022£905
2023—
2024—
Métrica2021202220232024
Beneficio / (pérdida)£0£0£0£0
Otros ingresos£1.628.440£1.628.440£3.652.957£3.913.386
Activo total£2.819.297£2.819.297£7.151.967£7.167.326
Net Assets Liabilities£2.819.297£2.819.297£7.151.967£7.167.326
Equity£2.819.297£2.819.297£7.151.967£7.167.326
Current Assets£29.659.379£29.659.379£37.203.541£44.146.534
Net Current Assets Liabilities£-4761£-4761£-4761£-4761
Total Assets Less Current Liabilities£2.819.297£2.819.297£7.151.967£7.167.326
Debtors£29.659.379£29.659.379£37.203.541£44.146.534
Creditors£29.664.140£29.664.140£37.208.302£44.151.295
Amounts Owed To Group Undertakings£29.659.379£29.659.379£37.208.302£44.151.295
Investments Fixed Assets£2.824.058£2.824.058£7.156.728£7.172.087
Issue Equity Instruments—£2.824.058£4.332.670£900.000
Number Shares Issued Fully Paid96.30196.301432.342.829432.342.829
Par Value Share£0£0£0£0
Gastos administrativos£4761£4761——
Accrued Liabilities Deferred Income£4761£4761——
Amounts Owed By Group Undertakings£29.659.379£29.659.379£37.203.541£44.146.534
Applicable Tax Rate£0£0——
Audit Fees Expenses£2000£2000——
Comprehensive Income Expense—£-4761£0£0
Fixed Assets£2.824.058£2.824.058£7.156.728£7.172.087
Further Item Increase Decrease In Equity Component Total Income Expense Recognised Directly In Equity———£15.359
Income Expense Recognised Directly In Equity—£2.824.058£4.332.670£15.359
Interest Income From Group Undertakings£1.628.440£1.628.440£3.652.957£3.913.386
Interest Paid To Group Undertakings£1.628.440£1.628.440£3.652.957£3.913.386
Interest Payable Similar Charges Finance Costs£1.628.440£1.628.440£3.652.957£3.913.386
Operating Profit Loss£-4761£-4761——
Other Interest Receivable Similar Income Finance Income£1.628.440£1.628.440£3.652.957£3.913.386
Percentage Class Share Held In Subsidiary£1£1£1£1
Profit Loss On Ordinary Activities After Tax£-4761£-4761£0£0
Profit Loss On Ordinary Activities Before Tax£-4761£-4761£0£0
Tax Expense Credit Applicable Tax Rate£-905£-905——
Tax Increase Decrease Arising From Group Relief Tax Reconciliation£905£905——

Documentos

Registration of particulars of charge

1/5/2026

Ver

Confirmation statement

5/2/2026

Ver

IA de documentos

Próximamente

Companexia Document AI

Haga preguntas sobre presentaciones y extractos—nuestra IA leerá los documentos y responderá en contexto.

Full accounts made up to 30 September 2024

27/6/2025

Ver

Change of director details

7/2/2025

Ver

Confirmation statement

6/2/2025

Ver

Change of details for relevant legal entity with significant control

1/10/2024

Ver

Change of director details

1/10/2024

Ver

Change of director details

1/10/2024

Ver

Annual Accounts

Cuentas del ejercicio que finaliza el: 30/9/2024

Archivado: 30/9/2024

Ver

Mostrando 1–10 de 41

1 / 5

Explorar más empresas y personas

🇮🇪KILDALE LIMITED🇮🇪PTMK HOLDINGS LIMITED🇮🇪ADVANCED FIRE CERT LIMITEDOLIVIER JACKY GROSSET-JANINCHRISTOPHER RIBE JMIKE HOLLIMAN
Ratio de fondos propios (2024)Ratio de fondos propios
100 %
Activos totales interanuales (2023 vs. 2024)Activos totales interanuales
+0,2 %
CAGR activos totales (2021–2024)CAGR activos totales
+36,5 %
Activo circulante neto (2024)Activo circulante neto
-4761 GBP

Salud financiera

Ratios derivados de las cuentas anuales. Se omiten los valores cuando faltan datos o no son significativos.

Crecimiento

Activos totales interanuales (2022 vs. 2023)
+153,7 %
Activos totales interanuales (2023 vs. 2024)
+0,2 %
CAGR activos totales (2021–2024)
+36,5 %

Capital circulante y liquidez

Activo circulante neto (2021)
-4761 GBP
Activo circulante neto (2022)
-4761 GBP
  1. –
  2. –
  3. –BIOSCRIPT MIDCO 2 LIMITED
Activo circulante neto (2023)
-4761 GBP
Activo circulante neto (2024)
-4761 GBP

Estructura de capital

Ratio de fondos propios (2021)
100 %
Ratio de fondos propios (2022)
100 %
Ratio de fondos propios (2023)
100 %
Ratio de fondos propios (2024)
100 %
Inicio
Reino Unido
Macclesfield